IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Atlas Venture Associates IX, LLC

Q1 2020 Holdings

Filed 2020-05-07 | 6 holdings | $47.3K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Intellia Therapeutics Inc(NTLA)COM45826J105$19.8K1,615,32141.8%
Spero Therapeutics Inc(SPRO)COM84833T103$11.1K1,376,96823.5%
Surface Oncology IncCOM86877M209$8.7K4,645,45318.4%
Synlogic IncCOM87166L100$4.6K2,651,9639.6%
Snap Inc(SNAP)CL A83304A106$1.8K150,1603.8%
Unum Therapeutics IncCOM903214104$1.4K3,361,5352.9%